HPS-123 - Evaluation of drug use in the treatment of encapsulating peritoneal sclerosis by tamoxifen

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HPS-123
• By: LI, Min-fen (Department Of Pharmacy, E-da Hospital, China Taiwan)
• Co-author(s): Ms Min-fen Li (Department Of Pharmacy, E-da Hospital, Kaohsiung, China Taiwan)
  Mr. Yung-Chia Hsu (Department Of Pharmacy, E-da Hospital, Kaohsiung, China Taiwan)
  Ms Hsiu-Ling Chang (Department Of Pharmacy, E-da Hospital, Kaohsiung, China Taiwan)
  
• Abstract:

  Introduction
  Tamoxifen is an empirical treatment for long-term peritoneal dialysis leading to encapsulating peritoneal sclerosis (EPS). Increased inflammatory reactions such as peritoneal infection or other irritant peritoneal cells associated with prolonged uremic toxins, glucose, acidic PH and glucose metabolites as patients with kidney wash..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login